SEC61B and colorectal carcinoma: The Sec61β autoantibody level in the plasma of patients was also significantly greater than that in the plasma of healthy controls, suggesting that the Sec61β autoantibody can be used as a new serum marker of CRC, especially in the early stage (Fan et al., 2011).